CDRH Patient Education Program: Patients as Advisors in Medical Device Clinical Studies

Why It Matters

Patient‑advisor involvement makes device trials more relevant, efficient, and likely to achieve regulatory approval, ultimately delivering safer, more usable technologies to patients faster.

Key Takeaways

• Patient advisors provide lived experience to shape device study design.
• Advisors can improve consent forms, recruitment materials, and participant retention.
• Involvement spans design, conduct, analysis, and dissemination stages of trials.
• FDA reviews submissions but does not conduct studies; companies drive advisor engagement.
• Advisor input leads to more patient‑centered outcomes and regulatory success.

Summary

The FDA’s CDRH Patient Education Program introduces patients as advisors in medical‑device clinical studies, explaining how lived‑experience contributors can influence the development lifecycle from discovery through post‑market.

The course defines a patient advisor as a non‑clinical participant who shares personal disease and device experience to improve study design, recruitment, consent language, and outcome relevance. Advisors may engage at any of the three development stages—discovery, clinical‑study/regulatory, and product‑launch/post‑market—though the training focuses on the clinical‑study phase.

Real‑world examples illustrate impact: Kay, a Parkinson’s patient, refined consent forms and highlighted meaningful endpoints for a deep‑brain‑stimulation trial; John, with obstructive sleep apnea, helped redesign recruitment flyers and extend clinic hours, reducing dropout rates; Carlos, a diabetes patient, contributed to continuous‑glucose‑monitor usability feedback. These stories show advisors shaping design, conduct, analysis, and dissemination.

Embedding patient advisors creates more patient‑centered trials, improves data quality, accelerates FDA review, and can shorten time‑to‑market for devices that truly meet user needs. Companies that adopt this model may gain competitive advantage while aligning with regulatory expectations for stakeholder engagement.

Original Description

FDA’s Center for Devices and Radiological has developed a series of courses about medical devices and the important role of patient advisors throughout the medical lifecycle. The courses are for patients, caregivers, patient organizations and industry and health care stakeholders who are interested in learning how to more effectively engage with FDA and Medical Device Developers.